The purpose of assessing dangerousness is to determine whether an individual poses a risk of endangering self or others now or in the near future and to identify what interventions are necessary to minimize that risk.
Informed assent, in which the family or surrogate decision makers for a patient are invited to defer to clinicians' judgment rather than specifically consenting to withholding or withdrawing futile treatments, is consistent with quality care and may protect surrogates from feeling responsible for the patient’s death.
Using evidence-based medical guidelines in courts will require confronting legal professionals' lack of training in assessing scientific evidence, the limitations of available evidence, and fundamental distinctions between the meaning of evidence in medicine and law.
The duty of forensic psychiatrists is to serve as objective experts to courts, but special circumstances in juvenile forensic evaluations and expectations about the patient-physician relationship may encourage confusion between the roles of forensic evaluator and treating psychiatrist.
Virtual Mentor interviews Dr. Sayeed to discuss the distinctive challenges of becoming a new mother. He also shares his insights on caring for terminally ill children and helping mothers and fathers come to terms with the unimaginable fact that their child is dying.
Even seasoned doctors can have trouble confronting the topic of death. For medical students, training and role modeling are needed to make them valuable to patients facing death.
Situations in which the patient’s family seems not to be acting in good faith or the patient's suffering is uncontrollable are relatively rare and do not warrant giving physicians unilateral power to withhold or withdraw treatment in all cases of perceived medical futility.
This month theme issue editor, Trahern Jones, a fourth-year student at Mayo Medical School in Rochester, Minnesota, spoke with Dr. Edward Laskowski about the use of performance-enhancing drugs and substances among athletes today.
Darryl C. Abrams, MD, Kenneth Prager, MD, Craig D. Blinderman, MD, Kristin M. Burkart, MD, MSc, and Daniel Brodie, MD
The medical community should formulate guidelines for appropriate use of organ-replacement therapies, taking into consideration the resources involved and the clinical expectation that the therapy can serve as a bridge to recovery or transplantation or can be a destination therapy.
Jalayne J. Arias, JD, MA and Kathryn L. Weise, MD, MA
Even when external factors such as nonaccidental injury weigh heavily on clinicians' perceptions, they should not lose focus on the patient's best interest when deciding whether to continue or withdraw treatment.